STAT

Physicians’ beliefs may override cancer patients’ wishes for end-of-life care, study finds

Spending on cancer care in the last month of life varies widely across the U.S. A new study points to physician attitudes as a major reason.
Source: John Moore/Getty Images

Dr. Nancy Keating has seen what too much health care looks like. The Harvard Medical School professor recalls a patient with metastatic lung cancer who, despite not wanting chemotherapy, was convinced by her doctor to try a more targeted treatment. The patient spent the end of her life in the hospital – the exact place she had hoped to avoid.

Keating, also a physician at Brigham and Women’s Hospital, studies how to deliver high-quality care to patients with cancer. Her latest work examines the factors that contribute to large hospital-by-hospital differences in end-of-life spending for cancer patients. The new study reveals that the variation in the intensity of treatment stems more from the availability of services and physicians’ discomfort navigating end-of-life choices than from patients’ wishes.

From surveys,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Oversight Of Shortages, AstraZeneca Threats, And More
Concerns have been raised over how the FDA maintains its list of drug shortages and which sources it relies on
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, What Drugmakers Didn’t Tell Alzheimer’s Trial Patients And More
Plus: Ozempic linked to a lower risk of Alzheimer’s diagnosis among people with type 2 diabetes
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Probe Of Pfizer And Lilly Telehealth, Pharma Exec Donations, And More
U.S. lawmakers demanded answers from Pfizer and Lilly about their relationships with telehealth prescribers

Related Books & Audiobooks